Form D · Other Health Care
Nuvalent, Inc.
Cambridge, MA · CIK 0001861560
Offering snapshot reported May 12, 2021 · SEC filing
- Reported sold
- $135M Offering amount: $135M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 12, 2021 | Initial | $134,999,971 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-399166
Source: Form D, filed May 12, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alex Porter Balcom | Executive |
| Gary Gilliland | Director |
| Andrew Hack | Director |
| Robert Jackson | Director |
| R. Porter James | Director, Executive |
| Joseph Pearlberg | Director |
| Matthew Shair | Director |
| Cameron Wheeler | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
One Broadway, 14 Th Floor
Cambridge, MA, 02142
Cambridge, MA, 02142